Posts tagged ALK-Rearranged Squamous Cell Lung Cancer
Clinical Benefit From a Combination of Brigatinib and Camrelizumab in Sarcomatoid Transformation of ALK-Rearranged Squamous Cell Lung Cancer Resistant to Crizotinib

A 27-year-old nonsmoking Chinese man was referred to the hospital owing to chest pain in May 2015. He had a diagnosis of stage IV lung squamous cell carcinoma (SCC), (cT2aN3M1b). Computed tomography displayed a 3-cm dense mass in the left superior lung (Fig. 1A, baseline), and immunohistochemistry (IHC) staining of the tumor biopsy reported positive for pulmonary SCC marker p40 (Fig. 1B, baseline). READ ARTICLE

JTO Clinical and Research Reports DOI:10.1016/j.jtocrr.2020.100009

Authors: Wei Jiang, Ruting Guan, Yang W. Shao, Bo Wang, Yina Wang

Read More